Home > Insider Trading > Filing (0001013237-20-000065)

Filing Details

Accession Number:: 0001013237-20-000065
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-15 17:06:09
Reporting Period:: 2020-04-13

Accepted Time:: 2020-04-15 17:06:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1013237	Factset Research Systems Inc	FDS	Services-Computer Programming, Data Processing, Etc. (7370)	133362547

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588985	Rebecca Rachel Stern	C/O Factset Research Systems, Inc. 45 Glover Avenue Norwalk CT 06850	Evp, Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-04-13	627	$0.00	0	No	5	G	Direct
Common Stock	Acquisiton	2020-04-14	2,680	$94.84	2,680	No	4	M	Direct
Common Stock	Acquisiton	2020-04-14	3,761	$92.22	6,441	No	4	M	Direct
Common Stock	Disposition	2020-04-14	1,680	$277.05	4,761	No	4	S	Direct
Common Stock	Disposition	2020-04-14	300	$278.46	4,461	No	4	S	Direct
Common Stock	Disposition	2020-04-14	200	$279.82	4,261	No	4	S	Direct
Common Stock	Disposition	2020-04-14	400	$282.86	3,861	No	4	S	Direct
Common Stock	Disposition	2020-04-14	100	$283.79	3,761	No	4	S	Direct
Common Stock	Disposition	2020-04-14	2,661	$277.29	1,100	No	4	S	Direct
Common Stock	Disposition	2020-04-14	300	$278.06	800	No	4	S	Direct
Common Stock	Disposition	2020-04-14	200	$279.26	600	No	4	S	Direct
Common Stock	Disposition	2020-04-14	600	$280.43	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	G	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-04-14	2,680	$0.00	2,680	$94.84
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-04-14	3,761	$0.00	3,761	$92.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-11-01	No	4	M	Direct
1,233		2022-11-01	No	4	M	Direct

Footnotes

This Transaction was a Bona Fide Gift. No compensation was given to the donor for the gifting of these shares.
This transaction was executed in multiple trades with sales prices ranging from $276.76 to $277.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $278.14 to $279.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $279.46 to $280.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $282.53 to $283.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $276.79 to $277.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $277.90 to $278.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $279.05 to $279.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades with sales prices ranging from $280.12 to $280.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Options granted on November 1, 2011 vest over a 5 year period with 20% exercisable one year after the grant date, with the remainder vesting at a rate of 1.67% per month thereafter.
Options granted on November 1, 2012 included both a time-based and performance-based component. This exercise included all of the outstanding time-based component, which vested over a 5 year period with 20% exercisable one year after the grant date, with the remainder vesting at a rate of 1.67% per month thereafter. The outstanding unexercised options are from the performance-based component, which vested based on the achievement by the issuer of certain financial performance criteria.